plasma soluble urokinase plasminogen activator receptor
Jump to navigation
Jump to search
Indications
- elevated plasma soluble urokinase plasminogen activator receptor may be used to assess indication for anakinra in treatment of Covid-19 pneumonia
More general terms
Additional terms
References
- ↑ Bassett M FDA Authorizes IL-1 Drug for Hospitalized COVID Patients. Anakinra indicated for patients with pneumonia who are at risk of severe respiratory failure. MedPage Today November 9, 2022 https://www.medpagetoday.com/infectiousdisease/covid19/101662